Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
SINGLETON J MATTHEW
Director at Viking Therapeutics. Filing since 31 May 2018.
CIK 0001243514
Company
Date
Role
Action
Shares
Amount
Of holding
VKTX
Viking Therapeutics, Inc.
25 Oct 2024
Director
Sold on a plan
16,000
$1.27M
62.7%
VKTX
Viking Therapeutics, Inc.
20 Sep 2024
Director
Sold on a plan
10,300
$715.85K
52.0%
VKTX
Viking Therapeutics, Inc.
21 Aug 2024
Director
Sold on a plan
5,700
$397.43K
37.5%
VKTX
Viking Therapeutics, Inc.
19 Aug 2024
Director
Sold on a plan
16,000
$995.45K
62.7%
VKTX
Viking Therapeutics, Inc.
14 Aug 2024
Director
Sold on a plan
20,786
$1.20M
68.6%
VKTX
Viking Therapeutics, Inc.
31 May 2018
Director
Bought
9,500
$93.26K
opened
6 decisions on file.
